What is Accumen?
Founded in 2011, Accumen specializes in providing strategic solutions and services designed to drive sustainable performance enhancements across healthcare ancillary services. The company's offerings encompass a broad spectrum, including lab and imaging transformation, supply chain optimization, consulting services, lab outreach programs, 3D post-processing, patient blood management, test utilization strategies, anemia management, and clinical data exchange. Accumen aims to optimize operational efficiencies and clinical outcomes for healthcare providers.
How much funding has Accumen raised?
Accumen has raised a total of $6.7M across 1 funding round:
Series A
$6.7M
Series A (2011): $6.7M with participation from Accretive LLC
Key Investors in Accumen
Accretive LLC
Accretive LLC is an investor with a focus on real estate management and development, particularly within the medical office asset sector. Their involvement suggests a strategic interest in the infrastructure supporting healthcare services.
What's next for Accumen?
With a history of securing substantial enterprise-level capital, Accumen is positioned for continued expansion and innovation in the healthcare performance sector. The company's focus on optimizing ancillary services, such as lab and imaging, suggests a strategic direction towards enhancing efficiency and cost-effectiveness within healthcare systems. Future growth is likely to involve further development of its consulting and transformation services, potentially leveraging its data exchange capabilities to provide deeper insights and integrated solutions for its clients. The recent funding, though undisclosed, indicates ongoing investor confidence in Accumen's business model and its capacity to address critical needs in the evolving healthcare landscape.
See full Accumen company page
